Overview: HIV1 RNA Quantitative TestIntroduction: The HIV1 RNA Quantitative Test quantifies HIV-1 viral RNA to monitor infection severity, preventing AIDS progression. Following 2023 DHHS guidelines, it uses PCR for high sensitivity, aiding in infectious disease screening. This test is critical for guiding antiretroviral therapy, assessing treatment response, and improving outcomes in virology for patients with HIV/AIDS, ensuring effective viral suppression.
Other Names: HIV 1 RNA Quant Assay, HIV Viral Load Test.
FDA Status: Laboratory-developed test (LDT), meeting virology standards for diagnostic accuracy.
Historical Milestone: HIV RNA quantification began in the 1990s with PCR development. Quantitative assays improved in the 2000s, enhancing treatment monitoring.
Purpose: Monitors HIV-1 infection severity, guides antiretroviral therapy, and quantifies HIV-1 RNA in patients to prevent AIDS progression.
Test Parameters: 1. HIV 1 RNA (Quantitative)
Pretest Condition: No fasting required. Collect plasma or serum at any time. Report history of HIV, treatment status, or symptoms like weight loss, and list medications.
Specimen: 2-4 mL plasma (EDTA) or 2-5 mL serum (SST). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document weight loss, opportunistic infections, or history of HIV treatment. Include current medications, especially antiretrovirals, and adherence history.
Consent: Written consent required, detailing the tests purpose, monitoring implications, and potential need for treatment adjustments.
Procedural Considerations: Uses PCR to quantify HIV-1 RNA levels. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for treatment monitoring.
Factors Affecting Result Accuracy: Improper sample handling, contamination, or low viral load can affect results. Antiretroviral therapy may suppress RNA levels.
Clinical Significance: High HIV-1 RNA levels indicate active infection, guiding antiretroviral therapy. Undetectable levels suggest treatment success, requiring confirmation.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and antiretroviral therapy planning.
Additional Supporting Tests: CD4 count, HIV resistance testing, or CBC to monitor HIV status and treatment efficacy.
Test Limitations: Low viral loads may be undetectable. Clinical correlation and serial testing are needed.
References: DHHS HIV Guidelines, 2023; Clinical Infectious Diseases, Saag MS, 2022.
